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ABSTRACT  
AIM: To monitor the trends in prevalence of CP by birthweight (BW) in Europe, 1980-2003. 
METHOD: Data were collated from twenty population-based registers contributing to the 
Surveillance of Cerebral Palsy in Europe database. Trend analyses were conducted in four 
BW groups: <1000g (ELBW), 1000-1499g (VLBW), 1500-2499g (MLBW) and >2499 g 
(NBW).  
RESULTS: The overall prevalence of CP decreased from 1.90 to 1.77 per 1000 LB, p<0.001, 
with a mean annual fall of 0.7% (95% CI -0.3 to -1.0%). Prevalence in NBW children showed 
a non-significant trend from 1.17 to 0.89 per 1000 LB (p=0.22). Prevalence in MLBW 
children decreased from 8.5 to 6.2 per 1000 LB (p<0.001), but not linearly. Prevalence in 
VLBW children also declined from 70.9 to 35.9 per 1000 LB (p<0.001) with a mean annual 
fall of 3.4% (95% CI -2.4% to -4.3%). Prevalence in ELBW children remained stable, at a 
mean rate of 42.4 per 1000 LB.  
INTERPRETATION: The decline in prevalence of CP in children of VLBW continues, and 
confirms that previously reported. For the first time, there is also a significant decline among 
those of MLBW, resulting in  a significant overall decrease in the prevalence of  CP  
Short title:  Prevalence in cerebral palsies 
 
What This Study Adds 
 We describe a further decrease in the prevalence of CP in children born of birthweight 
1000-1499g in 1980-2003, from that reported previously (1980-1996).  
 We report a significant reduction in the prevalence of CP in children of birthweight 
1500-2499g.  
 For the first time, this has result in a significant decrease in the overall prevalence of 
CP. 
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Cerebral palsy (CP) is the most common cause of significant motor impairment in 
children. It has many determinants, generally classified according to their time of onset; 
antenatal, perinatal or postnatal. 1 It is commonly perceived to result from multiple interacting 
factors and events rather than a single cause. 2  Changes in obstetric and neonatal practices 
over time have lead to the expectation that  the likelihood of a child developing CP will also 
change. In response to this, many areas  established population-based registers to monitor CP 
prevalence, with the aim of relating changes in prevalence to changes in antenatal, perinatal 
and postnatal care. 3 
A recent systematic review and meta-analysis estimated the prevalence of CP at 2.11/1000 
live births (LB) among children born since 1985. The authors concluded that the prevalence 
has not changed significantly in recent years; basing their conclusion on recently published 
studies.4 Prevalence estimation from meta-analysis of aggregated data from studies with 
heterogeneous inclusion and exclusion criteria is less robust than from estimation based on  
pooled individual data with homogeneous criteria. Furthermore, this study did not assess 
population changes over time, nor examine time trends within birthweight (BW) or 
gestational age (GA) specific groups. A recent review comparing prevalence trends, in CP 
overall and by GA groups from 1970 to 2004, drew on data from different population-based 
registers world-wide.5 However there are many challenges in interpretation differences or 
similarities when registers do not share the same harmonization methods . To our knowledge, 
there has been no recent published report of prevalence trends using pooled individual data 
from multisite population-based registers using an agreed data protocol. 
The Surveillance of Cerebral Palsy in Europe (SCPE) network was formed in 1998. It 
established a common database of individual data on those with CP with data contributed by 
population-based CP registers across Europe using agreed classifications, definitions, and 
shared quality assurance processes. It has previously described trends in CP prevalence by 
BW and GA groups in the pooled dataset,  demonstrating a decline in CP prevalence among 
children with BW below 1500g, from 60.6/1000 LB in 1980 to 39.5/1000 LB in 1996. 6 For 
children born between 32 and 36 weeks, the prevalence declined in a non-linear pattern 
between 1980 and 1998. The peak prevalence observed in 1983, was  12.2/1000 LB decrease 
thereafter. No significant change in prevalence has been reported in  children with moderately 
low BW (MLBW, 1500-2499g). 7 Similarly,  no significant change in the prevalence for 
children born with a normal BW (NBW, >2499g), has been reported, with a mean prevalence 
of 1.14/1000 between 1980 and 1998. 8   
There has been no recent, large-scale, population-based study exploring time trends in CP 
prevalence. The study reported here aims to address this by analysing data on CP by BW 
groups in Europe among children born in 1980 to 2003. 
METHOD 
Definition and classification 
All registers contributing to the SCPE network are population-based, covering either a region 
or a whole country in Europe. Data collection and harmonisation methods have been 
previously reported.9, 10 CP is defined as a group of permanent, but not unchanging, disorders 
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of movement and/or posture and of motor function, due to a non-progressive 
interference, lesion, or abnormality of the developing/immature brain. Progressive disorders 
or non-cerebral diseases leading to a loss of motor function are excluded. The diagnosis of CP 
should be confirmed at around the age of five. As previously described, subtypes of CP were 
are defined as unilateral spastic (US-CP), bilateral spastic (BS-CP), dyskinetic or ataxic. 11 
Severity of disability was defined, using  available data  from participating registries on 
intellectual quotient (IQ), Gross Motor Function Classification System (GMFCS), and 
walking ability, and classified as either  moderate-to-severe (children with IQ < 50 or 
GMFCS level III-V or not able to walk without assistive devices) or mild (children with IQ ≥ 
50 and either GMFCS level I-II or able to walk without assistive devices). Hierarchical trees 
developed by the SCPE network were used to operationalize the  inclusion and exclusion 
criteria and the classification  of CP subtypes to ensure consistency  across registers. 10, 11  ,  
To further enhance data harmonization across countries, SCPE developed a standardized data 
collection form and a reference and training manual CD-ROM translated into 12 languages.12 
For a full description, go to http://www.scpenetwork.eu. 
Study population 
In total, 26 population-based registers provided anonymized individual data to the SCPE 
common database for the whole or part of the period 1980-2003, representing 15 090 children 
with CP (Figure1). The children were categorized in four BW groups: <1000g (ELBW), 
1000-1499g (VLBW), 1500-2499g (MLBW) and >2499g (NBW). Inclusion criteria were as 
follows: children whose mothers lived in an area covered by a register at the time of delivery; 
(except for Grenoble, France, where important migration patterns led us to include the 
children living in the area at the time of registration instead); children registered in registers 
with annual population data for LB, stratified by BW, available for some or all of the study  
period. Exclusion criteria were: children with a post-neonatal onset, children from registries 
with a poor level completeness, children from registries with data on only one CP subtype or 
from registers with only one year of registration data. Data on neonatal deaths stratified by 
BW were provided by 10 registers and used in the results as an estimate for neonatal mortality 
in Europe during the study period. Data from a further six registries unable to provide such 
data were excluded.  
SCPE network has no specific ethical approval as it only gathers anonymized data. Each 
register had its own ethical approval that follows the legislative rules of its country.   
Statistical analysis 
To study changes in BW distribution of children with CP, we compared three time periods: 
1980─1987; 1988─1995; 1996─2003, using the Chi-squared test adjusted on register effect to 
take account of the fact that the number of contributing registers differed between the periods.  
Prevalence rates were calculated and are presented throughout the article per 1000 LB for all 
cases and for each BW group. Poisson regression was used to investigate trends in prevalence 
of CP. Poisson models were adjusted with offset terms to account for denominators. As 
different registers provided data covering different time periods, we followed several steps. 
Firstly, we analyzed trends in prevalence within each register. Secondly, we used pooled data 
to estimate trends in Europe. The initial model contained individual birth years. Addition of a 
term for register allowed for testing of  a register effect. This model allowed us to study the 
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trends in prevalence rates including data from registers unable to contribute data for 
the entire study period   Adding an interaction term between register and birth year provided a 
test for heterogeneity of trends between registers, using the median trend as the reference 
trend. In case of significant interaction, the register(s) responsible for interaction was(were) 
excluded. We also tested non-linearity of the trends using orthogonal polynomial terms for 
birth years up to third order. Likelihood-ratio Chi squared tests were used to compare nested 
models. To analyze the trends in prevalence, we also fitted mixed effects models . These 
yielded similar results as those presented in this article, i.e. without random effects.  
The threshold selected for overall analyses was p<0.005. The threshold for analyses of 
individual registers data was p<0.05. The figures show the birth prevalence of all CP and of 
moderate-to-severe CP in each BW group. Curves were smoothed using locally weighted 
scatterplot smoothing.13 Statistical analyses were performed using Stata Statistical software 
(version 12.0, Stata Corp., College Station, TX, USA). 
 
RESULTS 
A total of 10 756 children with CP from 20 registers covering a population of 5 382 785 
inhabitants were included in the analysis, (Table I). The prevalence of CP in 18 registers 
decreased linearly from 1.90 (99% CI 1.57─2.28) in 1980 to 1.77 (1.57─1.99) in 2003, 
p<0.001, a mean decrease of 0.7% per annum (95% CI -0.3 to -1.0%). Two registers 
(Slovenia and Portugal) showed significantly different trends from the others (p for 
interaction<0.001), each with a decrease more pronounced than the other registers. When 
restricting the analysis to the children with moderate-to-severe CP, there was no significant 
interaction, and a significant decline in prevalence was observed across the 20 registers, from 
0.98 (99%CI 0.75─1.26) to 0.72 (0.61─ 0.83), p<0.001, a mean annual fall of 1.8% per 
annum (95% CI -1.2 to -2.3%). 
Figure 2 shows the BW distribution among children with CP across three time periods. In the 
most recent time period (1996 to 2003) the proportion of both NBW and ELBW increased, 
with a concomitant decrease in those of MLBW (p<0.001). Within the ELBW group, the 
proportion of those <750g increased from 12% (14/117) in 1980─1987 to 33% (125/375) in 
1996─2003 (p for trend=0.002), and within the VLBW group, 48% (729/1530) had a BW 
between 1000─1250g with no significant change over time (p=0.91). The distribution of CP 
subtype by BW (Table II) showed a significant change over time only among spastic group, 
with a decrease in the proportion with bilateral spastic CP and a concomitant increase in the 
proportion with unilateral spastic subtype in both MLBW and NBW groups (p <0.001).  
Data on IQ were missing for 1760 children (16.4%) and GMFCS/walking for 597 children 
(5.6%). Data on severity were missing for 1201 children (11.2%). By period, severity was 
missing for 10.5% of children in 1980-1987, 7.8% of children in 1988-1995 and 13.8% of 
children in 1996-2003.  
The overall prevalence of CP among NBW children was 1.13 (5 492/4 872 419), with a non-
statistically significant decrease from 1.17 (99%CI 0.90─1.49) to 0.89 (0.77─1.03), p =0.22 
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(Figure 3a). The peak prevalence was 1.34 (1.08─1.64) in birthyear 1983. The 
moderate-to-severe CP subgroup also showed a non-statistically significant decrease, from 
0.52 (0.34─0.74) to 0.39 (0.31─ 0.48), p =0.02. During the same period, neonatal mortality 
for NBW children decreased significantly from 1.65 (CI 1.33─2.03) to 0.89 (0.75─1.05) per 
1000 LB (p <0.001). Among NBW children, the prevalence rate of children with bilateral 
spastic CP decreased significantly, with a mean annual fall of 1.4% per annum (95% CI -0.7% 
to -2.1%), p<0.001, falling  from 0.64 (0.49─0.83) to 0.35 (0.29─0.42). The prevalence rate 
of children with unilateral spastic CP increased significantly but not linearly, p=0.003. The 
peak prevalence was 0.55 in 1991 (0.44─0.66), followed by a plateau until 2000 and then a 
tendency to decrease.  
The overall prevalence of CP among MLBW children was 9.4 (2 336/249 393). It fell from 
8.5 (99%CI 5.4─12.7) to 6.2 (4.9─7.8), p <0.001, over the study period, although not linearly 
with a peak prevalence in 1983 (Figure 3b). For the moderate-to-severe CP, the prevalence 
decreased from 4.5 (2.3─7.7) to 3.2 (2.3─4.4), p <0.001; but again this was not linear, with a 
peak prevalence in 1988. During the same period, neonatal mortality for MLBW children 
decreased from 19.6 (14.7─25.6) to 9.3 (7.4─11.4) per 1000 LB (p <0.001). Among MLBW 
children, the prevalence rate of children with bilateral spastic CP decreased significantly but 
not linearly (p<0.001). The peak prevalence was 9.3 (7.0─12.2) in 1983 and the lowest 3.7 
(2.9─4.6) in 2003. The prevalence rate of children with unilateral spastic CP did not change 
significantly (p=0.54) over the period with a mean of 2.4 (2.2─2.6).  
The overall prevalence of CP among VLBW children was 52.1 (1507/28 900). It showed a 
linear decline from 70.9 (99%CI 41.7─110.9) to 35.9 (26.6─47.2), p <0.001, with a mean 
decrease per year of 3.4% (95% CI -2.4 to -4.3%) (Figure 3c). For the moderate-to-severe CP, 
the prevalence fell from 48.1 (24.7─83.0) to 17.1 (10.9─25.4), p <0.001 with a mean decrease 
per year of 5.2% (95% CI -3.9 to -6.4%). During the same period, neonatal mortality for 
VLBW children fell from 184.8 (137.3─240.1) to 45.0 (33.4─59.0) per 1000 LB (p <0.001), 
i.e. a 75% reduction. 
The overall CP prevalence for ELBW children was 42.4 (764/18 008), ranging from 40.9 
(99%CI 12.1─97.3) in 1980 to 38.2 (26.0─53.8) in 2003 (Figure 3d). There was no 
significant trend, (p =0.84) with non-linear increase until 1992. For the moderate-to-severe 
CP, the prevalence was also stable with a mean of 20.0 (SD 7.0). From 1980 to 2003, neonatal 
mortality for ELBW children decreased from 632 (531─725) to 316 (279─345) per 1000 LB 
(p <0.001). 
Eight registers were active during all  three time periods (Grenoble/ France, Cork/Ireland, 
Belfast/United Kingdom, Göteborg/Sweden, Dublin/Ireland, Newcastle/United Kingdom, 
Tonsberg/Norway, Rome/Italy) and collected data on 7464 of the children included in the 
SCPE common database. The analyses of trend restricted to these eight registries showed 
similar results as those found when using data from all registers participating in SCPE.   
DISCUSSION 
The analysis presented here provides an updated estimate of the prevalence of CP in Europe 
for the birth years 1980-2003, and is the first paper to show a significant decrease in both the 
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overall prevalence of CP within Europe, and in the prevalence of moderate-to-severe 
CP. It shows a significant reduction in the prevalence of CP among children of birthweight 
1500 to 2499 g (MLBW), and demonstrates a further reduction in the prevalence of CP in 
children with BW 1000-1499 g (VLBW) compared with that reported previously (1980-
1996).6  Although CP prevalence is still considerably higher in the lower BW groups, these 
findings provide important feed-back to obstetricians and neonatologists, and for child health 
systems in general, particularly as the decreased prevalence of CP among VLBW and MLBW 
infants accompanies a reduction in neonatal mortality of at least 50% across Europe. 
Although similar significant reductions are not also seen in NBW and ELBW groups, they are 
not increasing. Thus the work of SCPE, particularly when set alongside a continued decline in 
neonatal mortality rates in these groups and a more important decline in the moderate-to-
severe group, provides an encouraging message to both clinicians and parents. Among those 
of ELBW, the group considered at greatest risk of CP, the proportion of babies born with a 
BW of less than 750g, increased significantly from 12 to 33%, which may in part explain the 
lack of reduction in the prevalence of CP in this group.  
 
Epidemiological data from other countries and continents 
To our knowledge, in the United States, there are no published data of recent trends in CP 
prevalence by birthweight groups. The most recent report from The Metropolitan Atlanta 
Developmental Disabilities Surveillance Program (MADDSP), which monitors trends in 
childhood developmental disabilities, indicates a CP prevalence rate of 3.1 per 1000 8-year-
old children in 2008, 14 showing little change from the rate reported in 2002. 15 Using data 
from the National Health Interview Surveys, CP prevalence showed a small increase from 3.9 
to 4.3 per 1000 (1997 to 2002).16  However in this study, information on CP was parent-
reported, without confirmation from a clinical source. 
A follow-up study of extremely preterm babies (<28 weeks) born in Alberta, Canada reported 
similar CP prevalence and neonatal mortality rates to those reported here, 17 but data on less 
premature babies is not available for this population. In another Canadian province (Nova 
Scotia), while mortality rates declined between 1993 and 2007, CP rates in children born <31 
weeks showed steady increase until period 1998-2002 followed by a decrease.18  
SCPE data are best compared with data from the Australian Cerebral Palsy Register (ACPR). 
The ACPR monitors CP prevalence over time, using data from several Australian registers, 
and uses inclusion and exclusion criteria and a CP classification system similar to those used 
by SCPE. Their recent report,19 on children born 1993-2006,  showed similar trends in BW-
specific CP prevalence,  although the decrease in the VLBW group was only observed from 
birthyear 1998.  They also show a declining prevalence in the ELBW group, although this 
may reflect a different birth weight distribution within this ELBW group. Thus, data from two 
different continents with similar health care systems, and using similar methods suggest that 
the observed change in CP prevalence, even on a general level, is unlikely to be due to 
chance. 
Neonatal care 
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Over the period of study included in this paper, there have been many critical 
developments implemented in neonatal care. For very preterm born children, the 1990s saw 
an increasing use of steroids, in both the antenatal and postnatal period (until 
recommendations from paediatric academies and societies lead to a decline in their postnatal 
use.) 20 Other important changes include the introduction of surfactant, and improvement in 
the management of nosocomial infections. 21, 22 Overall, it is clearly recognized that these 
changes have led to a reduction in both mortality and impairment. 23, 24 However among 
ELBW infants, although the evolution of neonatal practice has had a significant impact on 
neonatal mortality, the impact on reduction of impairment is less evident. The results of the 
Epicure studies demonstrated that 20% of all babies born at 22 -25 weeks gestation in 2006 
had a severe disability, and that this proportion remained unchanged since 1995. 23  For term-
born children, the introduction of hypothermia treatment for hypoxic-ischemic 
encephalopathy after severe asphyxia is clearly a milestone in the care of these children. 
There is increasing evidence that its use is resulting in a decrease not only in mortality but 
also in CP. 25, 26 This treatment is now being used more widely, thus a potential reduction in 
CP prevalence among those of NBW group relating to this treatment would not yet be 
reflected in our analyses, which covered only birth years until 2003.  
Pathogenetic factors 
The global view, of an unchanging overall CP prevalence, has led in recent years to a 
discussion of genetic factors, and whether they may play a more important role in the 
pathogenesis of CP than previously considered. 27 However, several systematic reviews on 
magnetic resonance imaging (MRI) findings in children with CP indicate that brain 
maldevelopments, which may be due to monogenetic diseases, only account for 
approximately 10% of pathology in children with CP. 28, 29,30  
These reviews report that the most prevalent imaging findings among those with CP, 
accounting for 50 – 60% of cases, were white matter lesions such as periventricular 
leukomalacia (PVL) or sequelae of haemorrhage. They are typically lesions of the more 
immature brain 31 and are especially seen in preterm born children with CP (e.g. in around 
90%). From hospital-based studies, there is evidence for a decrease over time in PVL.32 van 
Haastert et al. described a decrease in cystic PVL of more than 50% between birth periods 
1990-93 and 2002-05. The most significant decrease (ten-fold) was seen in the severe form, 
i.e. cystic PVL III. 33 In contrast to PVL, there is no clear evidence for a decrease of severe 
intraventricular haemorrhage (IVH) in the preterm infant during the same time period. 34, 35 
PVL is typically bilateral, thus, when it affects the motor tracts, it usually gives rise to BS-CP. 
36 In contrast, severe IVH or haemorrhagic infarction usually have a unilateral impact on 
motor tracts and, thus, give rise to US-CP.37 These data also suggest that on a population 
basis, a decrease of CP in preterm born children, especially BS-CP, could be anticipated. 
Indeed, already our earlier papers have suggested this, 4,5 now confirmed in the data until birth 
year 2003, presented here. 
The MRI findings in NBW children with CP are more heterogeneous. 28-30 Findings 
suggestive of a prenatal origin of CP, e.g. maldevelopments of the brain or white matter 
lesions are predominant (around 15% and 20% respectively). Patterns that are compatible 
with an origin around the term account for around 30%. These include infarcts, where there is 
no evidence that peri- or neonatal care would influence their occurrence, and lesions 
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associated with hypoxia-ischemia following asphyxia and neonatal encephalopathy. 
The latter lesions arising in less than 20% of NBW children with CP are the only ones where 
neonatal care, such as hypothermia treatment could be expected to have an impact on CP 
prevalence. Thus, expectations for a change in CP prevalence, relating to changes in the 
neonatal management of such infants, will necessarily only address a small part of prevalence 
observed in term born children. It will be interesting to note any changes in the prevalence of 
CP in this group in the future. For some factors associated with CP among children born at 
term, i.e. non CNS abnormalities, placental status, young maternal age, socio-economic 
status, there are still inconsistencies in the literature, 38, 39 and more population based studies 
on larger number of children should be performed, with an international collaborative work 
allowing for meta-analysis of these factors. It has to be recognized, however, that in nearly 
one third of children born at term it is reported that no specific risk factors were present, i.e. 
much more often than among children born preterm (9%). 40  
Methodological considerations 
 The data used for this analysis were provided by 20 population-based registers from Europe, 
all members of the SCPE network, with a long history of harmonising data, and sharing data 
collection methods and inclusion/exclusion criteria. 10  Robust methods for analysing multi-
centre data and identifying ‘outliers’ were used. In addition, confidence in the results 
presented here is enhanced by the fact that the same trends were observed when restricted to 
the group of children with moderate-to-severe CP. Although the severity was not possible to 
assess for 11% of the children; this is unlikely to have biased our results. Indeed the lowest 
percentage of missing was seen in 1988-1995 and we observed a linear decrease in the 
moderate-to-severe prevalence rate.  
The time lag between the last birth cohort included in the analysis and the publication date of 
this paper is due to the age of confirmation of the diagnosis of CP and the practice of 
registration of CP in epidemiological studies to delay registration until aged 4-5. Further delay 
occurs due to the stringent data validation procedures established at both the individual 
register level and at SCPE Central registry level. The unavailability of information on live 
birth denominators by birth weight group in some of the administrative areas covered by the 
individual registers prevented performing the inclusion of all SCPE network registries in this 
analysis. The lack of centre-specific information for live births denominators by gestational 
age has made analysis by gestational age groups unfeasible at this stage.  
 
CONCLUSION: Continued collaboration of registers within the SCPE network has made it 
possible to demonstrate time trends in CP prevalence. CP prevalence has decreased in 
children born with moderately and very low birthweight, even in the presence of decreasing 
neonatal mortality. This paper has shown, for the first time, a decrease of the overall 
prevalence of CP, with a decrease of almost 2% per annum in moderate-to-severe CP. This 
paper has also shown how data on neonatal mortality and the prevalence of CP can improve 
understanding of the impact of improvements in neonatal care.  The introduction of a method 
to systematically record the results of brain imaging in children with CP may help to further 
understand mechanisms behind the changes in prevalence.   
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Table I. Number of children with CP and live births in the European registers included in the 
study.  
Location of register Available birth 
years  
Number of  
CP cases 
Number of 
 live births 
Grenoble, France  1980-2003  589 337 919 
Edinburgh, United Kingdom  1984-1989 679 389 338 
Cork, Ireland  1986-1998 185 100 541 
Belfast, United Kingdom 1981-2003 1223 549 505 
Göteborg, Sweden  1980-2003 1011 498 550 
Dublin, Ireland  1985-2003 785 385 438 
Newcastle, United Kingdom 1980-2003 1212 527 686 
Liverpool, United Kingdom 1980-1989 658 292 004 
Copenhagen, Denmark  1980-2003 2374 1 050 822 
Rome, Italy  1983-1998 85 39 270 
Tonsberg, Norway  1991-2003 668 421 312 
Bologna, Italy  1991-1996 59 37 255 
Galway, Ireland  1990-1998 98 66 475 
Madrid, Spain  1991-1999 93 54 851 
Ljubljana, Slovenia  1999-2003 195 87 474 
Lisbon, Portugal  2001-2003 514 339 870 
Riga, Latvia  2000-2003 46 24 467 
Pecs, Hungria  1999-2003  95 45 053 
Reykjavik, Iceland  1998-2003 57 24 876 
Innsbruck, Austria  1990-2003 130 110 079 
Total 1980-2003 10 756 5 382 785 
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Table II. Type of cerebral palsy according to birth weight of children between 1980 
and 2003 
Type of CP 1980-1987 
n (%) 
1988-1995 
n (%) 
1996-2003 
n (%) 
p* 
BW<1000g (ELBW), n=697 
Spastic 
BS-CP or bilateral 
US-CP or unilateral 
Dyskinetic 
Ataxic 
Unknown 
 
106 (90.6) 
73 (62.4) 
32 (27.3) 
4 (3v4) 
5 (4.3) 
2 (1.7) 
 
191 (93.2) 
141 (68.8) 
49 (23.9) 
8 (3.9) 
2 (1.0) 
4 (1.9) 
 
339 (90.4) 
241 (64.3) 
98 (26.1) 
13 (3.5) 
17 (4.5) 
6 (1.6) 
 
0.22 
0.49 
 
0.76 
0.86 
BW 1000-1499g (VLBW), n=1530 
Spastic 
BS-CP  
US-CP 
Dyskinetic 
Ataxic 
Unknown 
 
414 (92.2) 
324 (72.2) 
90 (20.0) 
25 (5.6) 
7 (1.6) 
3 (0.7) 
 
423 (94.6) 
338 (75.6) 
85 (19.0) 
19 (4.2) 
3 (0.7) 
2 (0.4) 
 
590 (93.1) 
452 (71.3) 
136 (21.4) 
27 (4.3) 
5 (0.8) 
12 (1.9) 
 
0.17 
0.08 
 
0.13 
0.84 
BW 1500-2499g (MLBW), n=2404 
Spastic 
BS-CP 
US-CP 
Dyskinetic 
Ataxic 
Unknown 
 
658 (91.6) 
492 (68.5) 
164 (22.8) 
34 (4.7) 
12 (1.7) 
14 (1.9) 
 
677 (92.1) 
494 (67.2) 
182 (24.8) 
41 (5.6) 
10 (1.4) 
7 (0.9) 
 
867 (91.2) 
592 (62.2) 
273 (28.7) 
46 (4.8) 
19 (2.0) 
19 (2.0) 
 
0.11 
<0.001 
 
0.53 
0.04 
BW≥2500g (NBW), n=5512 
Spastic 
BS-CP 
US-CP 
Dyskinetic 
Ataxic 
Unknown 
 
1176 (82.1) 
680 (47.4) 
495 (34.5) 
121 (8.4) 
82 (5.7) 
38 (2.6) 
 
1383 (84.1) 
718 (43.6) 
654 (39.8) 
147 (8.9) 
92 (5.6) 
23 (1.4) 
 
1995 (82.0) 
1002 (41.2) 
989 (40.6) 
264 (10.8) 
127 (5.2) 
48 (2.0) 
 
0.22 
<0.001 
 
0.22 
0.76 
Abbreviation: BW (Birth weight), BS-CP (Bilateral spastic cerebral palsy); US-CP (Unilateral 
spastic cerebral palsy) 
*p for trend adjusted on registers (spastic vs others known; BS-CP vs US-CP among spastic; 
Dyskinetic vs others known; Ataxic vs others known) 
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FIGURE CAPTIONS 
 
Figure 1. Flow chart  
Figure 2. Birth weight distribution of children with CP born between 1980 and 2003 in 
European registers.  
Figure 3a. Prevalence rate of cerebral palsy for children born with a birthweight ≥2500g, per 
1000 live births.  
Figure 3b. Prevalence rate of cerebral palsy for children born with a birthweight between 
1500 and 2499g, per 1000 live births. 
 Figure 3c. Prevalence rate of cerebral palsy for children born with a birthweight between 
1000 and 1499g, per 1000 live births. 
Figure 3d. Prevalence rate of cerebral palsy for children born with a birthweight below 1000g, 
per 1000 live births. 
 
 
